A Perspective on the Kinetics of Covalent and Irreversible Inhibition von Strelow, John M

Volltext

Nuisance compounds in cellular assays von Dahlin, Jayme L., Auld, Douglas S., Rothenaigner, Ina, Haney, Steve, Sexton, Jonathan Z., Nissink, J. Willem M., Walsh, Jarrod, Lee, Jonathan A., Strelow, John M., Willard, Francis S., Ferrins, Lori, Baell, Jonathan B., Walters, Michael A., Hua, Bruce K., Hadian, Kamyar, Wagner, Bridget K.

Volltext

Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor von Wijeratne, Aruna, Xiao, Junpeng, Reutter, Christopher, Furness, Kelly W, Leon, Rebecca, Zia-Ebrahimi, Mohammad, Cavitt, Rachel N, Strelow, John M, Van Horn, Robert D, Peng, Sheng-Bin, Barda, David A, Engler, Thomas A, Chalmers, Michael J

Volltext

The Use of Nucleosome Substrates Improves Binding of SAM Analogs to SETD8 von Strelow, John M., Xiao, Min, Cavitt, Rachel N., Fite, Nathan C., Margolis, Brandon J., Park, Kyu-Jin

Volltext

Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens von Gao, Cen, Margolis, Brandon J, Strelow, John M, Vidler, Lewis R, Mader, Mary M

Volltext

The identification of β-hydroxy carboxylic acids as selective MMP-12 inhibitors von Holmes, Ian P., Gaines, Simon, Watson, Steve P., Lorthioir, Olivier, Walker, Adam, Baddeley, Suzanne J., Herbert, Shane, Egan, Danielle, Convery, Máire A., Singh, Onkar M.P., Gross, Jeffrey W., Strelow, John M., Smith, Robert H., Amour, Augustin J., Brown, David, Martin, Stephen L.

Volltext

Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite von Deaton, David N, Gao, Enoch N, Graham, Kevin P, Gross, Jeffrey W, Miller, Aaron B, Strelow, John M

Volltext

Abstract 1259: Preclinical characterization of LY3537982, a novel, highly selective and potent KRAS-G12C inhibitor von Peng, Sheng-Bin, Si, Chong, Zhang, Youyan, Van Horn, Robert D., Lin, Xi, Gong, Xueqian, Huber, Lysiane, Donoho, Gregory, Curtis, Carmen, Strelow, John M., Bocchinfuso, Wayne P., Guo, Deqi, Boulet, Serge L., Barda, David, Manglicmot, Danalyn, Saflor, Melbert-Brian D., Wang, Jing, Xiao, Junpeng, Chalmers, Michael J., Burns, Lee, Linder, Ryan J., Ackermann, Bradley L., Cornwell, Paul D., Zhou, Lian, McCann, Denis, Henry, James

Volltext

Thiol-based angiotensin-converting enzyme 2 inhibitors: P 1 modifications for the exploration of the S 1 subsite von Deaton, David N., Gao, Enoch N., Graham, Kevin P., Gross, Jeffrey W., Miller, Aaron B., Strelow, John M.

Volltext

Thiol-based angiotensin-converting enzyme 2 inhibitors: P super(1) modifications for the exploration of the S super(1) subsite von Deaton, David N, Gao, Enoch N, Graham, Kevin P, Gross, Jeffrey W, Miller, Aaron B, Strelow, John M

Volltext

Thiol-based angiotensin-converting enzyme 2 inhibitors : P1modifications for the exploration of the S1 subsite von DEATON, David N, GAO, Enoch N, GRAHAM, Kevin P, GROSS, Jeffrey W, MILLER, Aaron B, STRELOW, John M

Volltext